📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Valaciclovir for Epstein-Barr Virus Suppression in Moderate-to-Severe COPD: A Randomized Double-Blind Placebo-Controlled Trial. (2023)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.chest.2023.03.040

PubMed Identifier: 37011709

Publication URI: http://europepmc.org/abstract/MED/37011709

Type: Journal Article/Review

Volume: 164

Parent Publication: Chest

Issue: 3

ISSN: 0012-3692